ArticleBMC surgery2026
The role of new generation inflammatory markers in patients undergoing carotid endarterectomy.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the prognostic value of novel systemic inflammatory markers, particularly the Systemic Immune-Inflammation Index (SII), in predicting morbidity and mortality in patients undergoing carotid endarterectomy.
methodsA retrospective analysis was conducted on 200 patients who underwent carotid endarterectomy. Patients were categorized into two groups based on their 1-year postoperative survival status (group-1:alive, group-2: dead). Inflammatory parameters including SII, neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)were calculated. Demographic, clinical, echocardiographic, and angiographic data were analyzed. The association between inflammatory markers and outcomes was assessed using univariate and multivariate analyses.
resultsSII, NLR and PLR were significantly higher in the group-2 (p < 0.001). Patients with internal carotid artery tortuosity exhibited longer operation times (p = 0.002), and those with elevated SII levels had a higher risk of adverse outcomes. No significant difference was observed in echocardiographic parameters between the two groups. The presence of comorbidities such as hyperlipidemia and coronary artery disease was also more prevalent in the group-2.
conclusionSystemic inflammatory markers, particularly SII, may serve as useful predictors of postoperative mortality and procedural complexity in patients undergoing carotid endarterectomy. Incorporating these markers into preoperative risk assessment may improve clinical decision-making and patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.